Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
contracted Covid-19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (contracted Covid-19) in a male patient of an unknown age who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: spikevax NOS (in the previous years.). Past adverse reactions to the above products included No adverse effect with spikevax NOS. In November 2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced COVID-19 (contracted Covid-19). At the time of the report, COVID-19 (contracted Covid-19) outcome was unknown. Concomitant product use was not provided by the reporter. Patient and their spouse both have received Spikevax in November 2024 as well as in the previous years. They both contracted Covid-19. It was unknown if the patient experienced any additional symptoms/events. Treatment information was not provided. Reporter causality was not reported. This case contains information for the 2nd patient out of 2 patients. This case was linked to US-MODERNATX, INC.-MOD-2025-784847 (E2B Linked Report). Reporter did not allow further contact; Sender's Comments: US-MODERNATX, INC.-MOD-2025-784847:Patient 2 of 2